A Simple Litmus Test for RFK Jr.’s Ideas
The media describes the new HHS chief as a conspiracy theorist. But how many of his ideas are actually used in Europe? More than you’d think.
Related Articles
Survival benefit associated with liver transplantation for… : Hepatology Communications
characteristics. This study assessed whether transplant-associated survival benefits (TASBs) vary among patients with different tumor burden scores (TBS) measured at the time of listing. Methods:…
Randomized Trial of Enhanced Versus Standard Navigation to Promote Timely Initiation of Adjuvant Radiotherapy for Head and Neck Cancer | JCO Oncology Practice
PURPOSENational Comprehensive Cancer Network Guidelines recommend initiating postoperative radiation therapy (PORT) within 6 weeks of surgery for patients with head and neck squamous cell carcinoma…
Treatment of Pleural Mesothelioma: ASCO Guideline Update
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the…
Mailbag: Letters of Intent and Post-Interview Communication
Will it improve my chances of matching to tell a program that I’m ranking them #1? What about if I just say I’m ranking their…
Home
Thank you for supporting the ASH Foundation. Your generosity enables the Foundation to provide critical support to the field of hematology through programs in resea…
Home | Conquer Cancer, the ASCO Foundation
Your gift can help conquer cancer around the world. Researchers are making amazing advances in the treatment and prevention of cancer, thanks to contributions from…
Belantamab + Standard of Care for Newly Diagnosed Myeloma (DreaMM-9) | Saad Usmani, MD | #ASH24
Dr Saad Usmani discusses a study looking at belantamab combined with the standard of care for newly diagnosed multiple myeloma. Link to ASH playlist: https:/…
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial
Nature Medicine – In this phase 1 trial, patients with locally advanced or metastatic solid tumors were treated with the individualized mRNA neoantigen-specific immunotherapy (iNeST)…
What Do Recent Clinical Trials Reveal About Biomarkers for Adjuvant Treatment in Localized RCC, and What’s Still Missing?
Among patients with high-risk localized renal cell carcinoma, recurrence rates range from 40% to 50% after partial or radical nephrectomy, establishing a critical need for…
